Related Experiment Video
Updated: Jun 4, 2026

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
The type I interferon system in the development of lupus
Lars Rönnblom1, Gunnar V Alm, Maija-Leena Eloranta
1Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden. Lars.Ronnblom@medsci.uu.se
The type I interferon (IFN) system, crucial for antiviral defense, may drive autoimmune diseases like lupus. Overexpression of IFN-regulated genes and IFN-alpha
Area of Science:
- Immunology
- Rheumatology
- Virology
Background:
- The type I interferon (IFN) system plays a dual role in immunity, inhibiting viral replication while activating innate and adaptive immune responses.
- Autoimmune diseases, particularly lupus, are characterized by the overexpression of type I IFN-regulated genes, suggesting a significant role for this system.
- Therapeutic use of IFN-alpha has been linked to the development of autoimmune conditions, further implicating type I IFNs in breaking immune tolerance.
Purpose of the Study:
- To review the potential involvement of the type I interferon system in the pathogenesis of lupus.
- To explore the interplay between type I IFN signaling and known genetic and environmental risk factors for lupus.
Main Methods:
- This is a review article, synthesizing existing research on type I IFNs and lupus.
- The review discusses observations from clinical studies, genetic analyses, and environmental risk factor research.
Main Results:
- Elevated type I IFN activity is a hallmark of lupus, indicated by gene expression patterns.
- Genetic predispositions for increased type I IFN production or response are observed in lupus patients.
- Environmental factors associated with lupus may also stimulate type I IFN production, contributing to disease initiation or flares.
Conclusions:
- The type I interferon system is strongly implicated in the development and progression of lupus.
- A combination of genetic susceptibility and environmental triggers likely promotes chronic type I IFN activity in lupus patients.
- Further research into the type I IFN pathway could reveal novel therapeutic targets for lupus treatment.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Type I Diabetes II: Pathophysiology
What is the Immune System?
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Type I Diabetes I: Introduction

